A Study of Avutometinib for People With Solid Tumor Cancers

NCT06104488 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

23

Enrollment

OTHER

Sponsor class

Conditions

Refractory Cancer
CNS Tumors
CNS Tumor, Adult
CNS Tumor, Childhood
MAP Kinase Family Gene Mutation
NF1
Plexiform Neurofibroma
Low-grade Glioma
Optic Pathway Gliomas
Neuroblastoma
Primary Brain Tumor
Solid Tumor
Solid Tumor, Adult
Solid Carcinoma
Central Nervous System Tumor

Interventions

DRUG: Avutometinib

Sponsor

Memorial Sloan Kettering Cancer Center